1. Home
  2. CDZIP vs CGEN Comparison

CDZIP vs CGEN Comparison

Compare CDZIP & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CDZIP

Cadiz Inc.

HOLD

Current Price

$21.76

Market Cap

0.0

Sector

Utilities

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.37

Market Cap

191.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDZIP
CGEN
Founded
N/A
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
191.1M
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
CDZIP
CGEN
Price
$21.76
$2.37
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $5.00
AVG Volume (30 Days)
4.8K
★ 211.2K
Earning Date
N/A
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 9.43
N/A
EPS
N/A
★ N/A
Revenue
★ $16,313,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$75.09
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 69.79
N/A
52 Week Low
$18.80
$1.37
52 Week High
$24.78
$3.24

Technical Indicators

Market Signals
Indicator
CDZIP
CGEN
Relative Strength Index (RSI) 43.78 41.25
Support Level $21.65 $2.34
Resistance Level $22.73 $2.54
Average True Range (ATR) 0.44 0.08
MACD -0.03 -0.02
Stochastic Oscillator 57.69 14.06

Price Performance

Historical Comparison
CDZIP
CGEN

About CDZIP Cadiz Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, generating maximum revenue engaged in providing water filtration solutions for impaired or contaminated groundwater sources.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: